PLOS Neglected Tropical Diseases Analyzing a survey carried out in Jordan, the West Bank, and Syria, this article reports that two-thirds of respondents were “unwilling or hesitant” to receive a COVID-19 vaccine. Journal Article
Read MoreThe New England Journal of Medicine Based on a study conducted in Qatar, this study investigated vaccine-induced protection against severe SARS-COV-2 infection and hospitalization. Journal Article
Read MoreVaccines This article reports that students with greater confidence in COVID-19 information, and higher perceived likelihood and perceived severity of infection were more likely to be willing to get the vaccine. Journal Article
Read MoreSMEX SMEX discusses digital rights in the region in 2021 and highlights COVID-19- related challenges like the digitization of health documents and a digital vaccine passport. Article
Read MoreOpen Journal of Internal Medicine This paper measures the acceptance of a COVID-19 vaccine among adults working in oil companies in Kuwait. Of the surveyed participants, 92.5 percent demonstrated a willingness to receive a COVID-19 vaccine. Journal Article
Read MorePreventive Medicine Reports This article reports that a third of older Syrian refugees had no intention to receive the COVID-19 vaccine. Journal Article
Read MoreIJID Regions This article investigates coronavirus vaccine hesitancy among healthcare workers in the UAE. UAE healthcare workers had a high acceptance rate (89.2%) for COVID-19 vaccines. Journal Article
Read MoreStatista In 2020, poverty in Algeria was projected to increase due to the coronavirus (COVID-19) outbreak. During the pandemic, 26.5 percent of the Algerian population was projected to be living with less than 5.5 U.S. dollars per day, while 3.3 percent with less than 3.2 U.S. dollars per day. Considering both poverty lines, poverty was…
Read MoreBMC Public Health This article investigates the determinants of vaccine acceptance among Syrians. Journal Article
Read MoreUSNews The national research body of Egypt announced the beginning of clinical trials for a domestically manufactured COVID-19 vaccine. Article
Read More